Clin2
NCT06763081Possibly a fitRecruiting

SSRI side effects genetics study

Behavioral ActivationMajor Depressive DisorderAnxiety DisordersAntidepressant Drug Adverse ReactionObsessive Compulsive Disorder (OCD)Major Depression

Part of Mental health clinical trials.

This study looks at why some people have behavioral side effects when taking SSRI antidepressants like Prozac or Zoloft. It hopes to find a genetic reason to help doctors choose safer treatments in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
160 people
Ages
6 years to 24 years
Study type
Observational

Who can take part

  • You live in Manitoba.
  • You are between 6 and 24 years old.
  • You have depression, anxiety, or OCD.
  • You have taken an SSRI (like Celexa, Prozac, Zoloft) in the past or now.
  • If you had behavioral side effects from an SSRI (like restlessness or agitation) that went away after stopping or lowering the dose, you may be a 'case'.
  • If you took an SSRI for 8 weeks without any side effects, you may be a 'control'.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03953014Recruiting
Genetic study of antidepressant side effects in young people

This trial studies whether genes (using a saliva sample) can help explain why some young people feel more “disinhibited” after taking antidepressants like SSRIs. If you’ve had depression, anxiety, or OCD and have used an SSRI, your information and genetics may help improve how antidepressants are chosen and monitored.

Calgary, Alberta
NCT07649993Not yet recruiting
Gene Expression Study in Psychiatric Conditions

This research study examines how certain genes are expressed (turned on or off) in people with psychiatric conditions like bipolar disorder, depression, panic disorder, OCD, or schizophrenia. The study compares gene expression in patients with these conditions to healthy volunteers to better understand what happens at a biological level.

Catania, Sicily
NCT06081348Recruiting· Phase 2
Sertraline vs. placebo for anxiety in kids with developmental disorders

This trial compares sertraline (a common antidepressant) to a placebo (a pill with no medicine) to see which better reduces anxiety in children and teens who also have a neurodevelopmental disorder like autism, ADHD, or Tourette's. The goal is to help you and your child understand if this treatment might offer relief from anxiety.

Calgary, Alberta
NCT04221997Recruiting· Phase 4
Sertraline study for anxious children and teens

This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.

Cincinnati, Ohio
NCT06853587Recruiting
Genetic test to help pick antidepressant for teens

This study tests whether using a cheek swab DNA test can help choose a better antidepressant for teenagers with anxiety or depression. The goal is to see if this personalized approach leads to fewer side effects and better results.

Calgary, Alberta
NCT02431845Recruiting
Study of OCD genes, proteins, and gut microbes

This study looks at genes, blood/brain proteins, and gut microbes in people with obsessive-compulsive disorder (OCD). It may help researchers understand what drives OCD and how treatments could be better tailored in the future.

Seoul

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.